ROCKETSCRIPT

Serial Number 88018527
Registration 5941246
701

Registration Progress

Application Filed
Jun 28, 2018
Under Examination
Approved for Publication
Oct 8, 2019
Published for Opposition
Oct 8, 2019
Registered
Dec 24, 2019

Trademark Image

ROCKETSCRIPT

Basic Information

Serial Number
88018527
Registration Number
5941246
Filing Date
June 28, 2018
Registration Date
December 24, 2019
Published for Opposition
October 8, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
701
Status Date
Jun 5, 2025
Registration
Registered
Classes
001 005

Rights Holder

BIONEER CORPORATION

03
Address
8-11, Munpyeongseo-ro, Daedeok-gu
Daejeon 34302
KR

Ownership History

BIONEER CORPORATION

Original Applicant
03
Daejeon KR

BIONEER CORPORATION

Owner at Publication
03
Daejeon KR

BIONEER CORPORATION

Original Registrant
03
Daejeon KR

Legal Representation

Attorney
Steven J. Hultquist

USPTO Deadlines

Next Deadline
1504 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-12-24)
Due Date
December 24, 2029
Grace Period Ends
June 24, 2030

Application History

23 events
Date Code Type Description Documents
Jun 5, 2025 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
Jun 5, 2025 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
May 26, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 14, 2025 ES8R I TEAS SECTION 8 RECEIVED Loading...
Dec 24, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 24, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 8, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 8, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 18, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 3, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 30, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 30, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 29, 2019 ALIE A ASSIGNED TO LIE Loading...
Aug 23, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Apr 24, 2019 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Apr 24, 2019 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Apr 24, 2019 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Oct 22, 2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 22, 2018 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Oct 22, 2018 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 19, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 3, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 2, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
biological enzymes for non-medical use; compositions for use in cDNA synthesis for research purposes; kits for use in cDNA synthesis for research purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for research purposes; kits for use in nucleic acid fluorescence staining for research purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for research purposes; kits for use in DNA sequence analysis for research purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for research purposes; compositions for use in nucleic acid amplification for research purposes; kits for use in nucleic acid amplification for research purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for research purposes; compositions for use in polymerase chain reaction for research purposes; compositions for use in reverse transcription for research purposes
Class 005
biological enzymes for medical use; kits for use in cDNA synthesis for medical purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for medical purposes; kits for use in nucleic acid fluorescence staining for medical purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for medical purposes; kits for use in DNA sequence analysis for medical purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for medical purposes; compositions for use in nucleic acid amplification for medical purposes; kits for use in nucleic acid amplification for medical purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for medical purposes; compositions for use in nucleic acid amplification for medical purposes; compositions for use in reverse transcription for medical purposes

Additional Information

Pseudo Mark
ROCKET SCRIPT

Classification

International Classes
001 005